Shames Richard S. 4
4 · Protagonist Therapeutics, Inc · Filed Dec 27, 2017
Insider Transaction Report
Form 4
Shame Richard S
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2017-12-22$4.21/sh+3,529$14,857→ 3,529 total - Exercise/Conversion
Stock Option (right to buy)
2017-12-22−3,529→ 33,273 totalExercise: $4.21Exp: 2026-04-29→ Common Stock (3,529 underlying) - Sale
Common Stock
2017-12-22$20.50/sh−3,529$72,345→ 0 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017.
- [F2]The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.